Delays in Core Laboratory Testing, December 10, 2014

On Wednesday, December 10, 2014, instrumentation in the core clinical laboratory will be undergoing required maintenance from approximately 09:30 – 12:30.  This will delay the resulting of the following assays in that time window:

Alpha-1 antitrypsin [LAB927]
Angiotensin converting enzyme [LAB563]
Amikacin drug level [Epic LAB555]
Carbamazepine drug level [Epic LAB22]
Drug of abuse – urine screens [Epic LAB500 and LAB1032]
Ethylene glycol, plasma (by immunoassay) [LAB7453]
Everolimus drug level [LAB7456]
Homocysteine [LAB93]
IgA [LAB73]
IgG [LAB71]
IgM [LAB72]
Keppra (levetiracetam) drug level [LAB477]
Lamotrigine drug level (LAB475]
Lidocaine drug level [LAB641]
Methotrexate drug level [Epic LAB481]
Pentobarbital drug level [LAB656]
Phenobarbital drug level [Epic LAB30]
Phenytoin free drug level [Epic LAB32]
Rheumatoid factor [LAB206]
Theophylline drug level [LAB35]
Tobramycin drug level [Epic LAB36]
Valproic acid drug level [Epic LAB25]

Questions should be directed to Matthew Krasowski, MD, PhD, medical director of the Clinical Chemistry Laboratory (384-9380,